{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T04:04:22Z","timestamp":1748750662076,"version":"3.41.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,30]]},"DOI":"10.7759\/cureus.85108","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T03:38:31Z","timestamp":1748662711000},"source":"Crossref","is-referenced-by-count":0,"title":["Rapidly Progressive Joint Destruction in Idiopathic Multicentric Castleman\u2019s Disease: A Case Report"],"prefix":"10.7759","author":[{"given":"Haruki","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Tasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyoshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/02841860410002752","article-title":"Fifty years of multicentric Castleman's disease","volume":"43","author":"Waterston A","year":"2004","unstructured":"Waterston A, Bower M. Fifty years of multicentric Castleman's disease. Acta Oncol. 2004, 43:698-704. 10.1080\/02841860410002752","journal-title":"Acta Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum DC","year":"2017","unstructured":"Fajgenbaum DC, Uldrick TS, Bagg A, et al.. International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease. Blood. 2017, 129:1646-57. 10.1182\/blood-2016-10-746933","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.4.1360.1360","article-title":"Pathogenic significance of interleukin-6 (IL-6\/BSF-2) in Castleman's disease","volume":"74","author":"Yoshizaki K","year":"1989","unstructured":"Yoshizaki K, Matsuda T, Nishimoto N, et al.. Pathogenic significance of interleukin-6 (IL-6\/BSF-2) in Castleman's disease. Blood. 1989, 74:1360-7. 10.1182\/blood.V74.4.1360.1360","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24242","article-title":"Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease","volume":"91","author":"Iwaki N","year":"2016","unstructured":"Iwaki N, Fajgenbaum DC, Nabel CS, et al.. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol. 2016, 91:220-6. 10.1002\/ajh.24242","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03494-2","article-title":"Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases","volume":"147","author":"Sun DP","year":"2021","unstructured":"Sun DP, Chen WM, Wang L, et al.. Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases. J Cancer Res Clin Oncol. 2021, 147:2107-15. 10.1007\/s00432-020-03494-2","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac481","article-title":"Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis","volume":"62","author":"Gonz\u00e1lez Garc\u00eda A","year":"2023","unstructured":"Gonz\u00e1lez Garc\u00eda A, Fern\u00e1ndez-Mart\u00edn J, Robles Marhuenda \u00c1. Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis. Rheumatology (Oxford). 2023, 62:1426-35. 10.1093\/rheumatology\/keac481","journal-title":"Rheumatology (Oxford)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2018.1532383","article-title":"A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease","volume":"29","author":"Koga T","year":"2019","unstructured":"Koga T, Sumiyoshi R, Kawakami A, Yoshizaki K. A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease. Mod Rheumatol. 2019, 29:302-5. 10.1080\/14397595.2018.1532383","journal-title":"Mod Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S175763","article-title":"Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats","volume":"12","author":"Dai Q","year":"2018","unstructured":"Dai Q, Zhou D, Xu L, Song X. Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats. Drug Des Devel Ther. 2018, 12:4095-105. 10.2147\/DDDT.S175763","journal-title":"Drug Des Devel Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108793","article-title":"Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis","volume":"230","author":"Liu S","year":"2021","unstructured":"Liu S, Ma H, Zhang H, Deng C, Xin P. Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis. Clin Immunol. 2021, 230:108793. 10.1016\/j.clim.2021.108793","journal-title":"Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13974","article-title":"Prevalence of patients with rheumatoid arthritis and age-stratified trends in clinical characteristics and treatment, based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan","volume":"23","author":"Nakajima A","year":"2020","unstructured":"Nakajima A, Sakai R, Inoue E, Harigai M. Prevalence of patients with rheumatoid arthritis and age-stratified trends in clinical characteristics and treatment, based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan. Int J Rheum Dis. 2020, 23:1676-84. 10.1111\/1756-185X.13974","journal-title":"Int J Rheum Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.19021","article-title":"Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan","volume":"59","author":"Masaki Y","year":"2019","unstructured":"Masaki Y, Kawabata H, Fujimoto S, et al.. Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan. J Clin Exp Hematop. 2019, 59:175-8. 10.3960\/jslrt.19021","journal-title":"J Clin Exp Hematop"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.48.4.326","article-title":"Multicentric Castleman's disease associated with rheumatoid arthritis: a possible role of hepatitis B antigen","volume":"48","author":"Ben-Chetrit E","year":"1989","unstructured":"Ben-Chetrit E, Flusser D, Okon E, Ackerman Z, Rubinow A. Multicentric Castleman's disease associated with rheumatoid arthritis: a possible role of hepatitis B antigen. Ann Rheum Dis. 1989, 48:326-30. 10.1136\/ard.48.4.326","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015237","article-title":"Rheumatoid arthritis-like active synovitis with T-cell activation in a case of idiopathic multicentric Castleman disease: a case report","volume":"98","author":"Otsuka M","year":"2019","unstructured":"Otsuka M, Koga T, Sumiyoshi R, et al.. Rheumatoid arthritis-like active synovitis with T-cell activation in a case of idiopathic multicentric Castleman disease: a case report. Medicine (Baltimore). 2019, 98:e15237. 10.1097\/MD.0000000000015237","journal-title":"Medicine (Baltimore)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/mrcr\/rxac003","article-title":"A patient with Castleman's disease initially manifesting symmetrical synovitis with pitting oedema","volume":"6","author":"Kondo J","year":"2022","unstructured":"Kondo J, Arinuma Y, Matsueda Y, et al.. A patient with Castleman's disease initially manifesting symmetrical synovitis with pitting oedema. Mod Rheumatol Case Rep. 2022, 6:309-13. 10.1093\/mrcr\/rxac003","journal-title":"Mod Rheumatol Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-155846","article-title":"Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease","volume":"112","author":"Nishimoto N","year":"2008","unstructured":"Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood. 2008, 112:3959-64. 10.1182\/blood-2008-05-155846","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.9.2587.2587","article-title":"Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome","volume":"83","author":"Gherardi RK","year":"1994","unstructured":"Gherardi RK, Belec L, Fromont G, et al.. Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome. Blood. 1994, 83:2587-93. 10.1182\/blood.V83.9.2587.2587","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01208.x","article-title":"Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease","volume":"104","author":"Nishi J","year":"1999","unstructured":"Nishi J, Arimura K, Utsunomiya A, et al.. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease. Br J Haematol. 1999, 104:482-5. 10.1046\/j.1365-2141.1999.01208.x","journal-title":"Br J Haematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.22010","article-title":"Candidate biomarkers for idiopathic multicentric Castleman disease","volume":"62","author":"Sumiyoshi R","year":"2022","unstructured":"Sumiyoshi R, Koga T, Kawakami A. Candidate biomarkers for idiopathic multicentric Castleman disease. J Clin Exp Hematop. 2022, 62:85-90. 10.3960\/jslrt.22010","journal-title":"J Clin Exp Hematop"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.46627","article-title":"The role of autophagy and mitophagy in bone metabolic disorders","volume":"16","author":"Wang S","year":"2020","unstructured":"Wang S, Deng Z, Ma Y, et al.. The role of autophagy and mitophagy in bone metabolic disorders. Int J Biol Sci. 2020, 16:2675-91. 10.7150\/ijbs.46627","journal-title":"Int J Biol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-023-03181-w","article-title":"Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis","volume":"25","author":"Zhang F","year":"2023","unstructured":"Zhang F, Cheng T, Zhang SX. Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis. Arthritis Res Ther. 2023, 25:187. 10.1186\/s13075-023-03181-w","journal-title":"Arthritis Res Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-021-06986-7","article-title":"A molecular insight of inflammatory cascades in rheumatoid arthritis and anti-arthritic potential of phytoconstituents","volume":"49","author":"Patidar V","year":"2022","unstructured":"Patidar V, Shah S, Kumar R, Singh PK, Singh SB, Khatri DK. A molecular insight of inflammatory cascades in rheumatoid arthritis and anti-arthritic potential of phytoconstituents. Mol Biol Rep. 2022, 49:2375-91. 10.1007\/s11033-021-06986-7","journal-title":"Mol Biol Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/art.42759","article-title":"Amino acids fueling fibroblast-like synoviocyte activation and arthritis by regulating chemokine expression and leukocyte migration","volume":"76","author":"Karonitsch T","year":"2024","unstructured":"Karonitsch T, Saferding V, Kieler M, et al.. Amino acids fueling fibroblast-like synoviocyte activation and arthritis by regulating chemokine expression and leukocyte migration. Arthritis Rheumatol. 2024, 76:531-40. 10.1002\/art.42759","journal-title":"Arthritis Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/371870-rapidly-progressive-joint-destruction-in-idiopathic-multicentric-castlemans-disease-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T03:38:31Z","timestamp":1748662711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/371870-rapidly-progressive-joint-destruction-in-idiopathic-multicentric-castlemans-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.85108","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}